Cardiovascular Revascularization Medicine
Volume 10, Issue 4 , Pages 236-246 , October 2009

Late-acquired incomplete stent apposition: morphologic characterization

Received 24 January 2009 ,Accepted 4 February 2009.

References 

  1. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: a serial intravascular ultrasound analysis. J Am Coll Cardiol. 2005;46:1002–1005
  2. Honda Y, Grube E, de La Fuente LM, Yock PG, Stertzer SH, Fitzgerald PJ. Novel drug-delivery stent: intravascular ultrasound observations from the first human experience with the QP2-eluting polymer stent system. Circulation. 2001;104:380–383
  3. Serruys PW, Degertekin M, Tanabe K, Abizaid A, Sousa JE, Colombo A, et al. Intravascular ultrasound findings in the multicenter, randomized, double-blind RAVEL (RAndomized study with the sirolimus-eluting VElocity balloon-expandable stent in the treatment of patients with de novo native coronary artery Lesions) trial. Circulation. 2002;106:798–803
  4. Kozuma K, Costa MA, Sabate M, Serrano P, van der Giessen WJ, Ligthart JM, et al. Late stent malapposition occurring after intracoronary beta-irradiation detected by intravascular ultrasound. J Invasive Cardiol. 1999;11:651–655
  5. Hong MK, Mintz GS, Lee CW, Kim YH, Lee SW, Song JM, et al. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation. Circulation. 2004;109:881–886
  6. Mintz GS, Shah VM, Weissman NJ. Regional remodeling as the cause of late stent malapposition. Circulation. 2003;107:2660–2663
  7. Nakamura M, Kataoka T, Honda Y, Benneau HN, Hibi K, Kitamura K, et al. Late incomplete stent apposition and focal vessel expansion after bare metal stenting. Am J Cardiol. 2003;92:1217–1219
  8. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: insights from the randomized TAXUS II trial. Circulation. 2005;111:900–905
  9. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation. 2007;115:2426–2434
  10. Siqueira DA, Abizaid AA, Costa Jde R, Feres F, Mattos LA, Staico R, et al. Late incomplete apposition after drug-eluting stent implantation: incidence and potential for adverse clinical outcomes. Eur Heart J. 2007;28:1304–1309
  11. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. Polymer-based paclitaxel-eluting stents reduce in-stent neointimal tissue proliferation: a serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol. 2005;45:1201–1205
  12. Kalinczuk L, Pregowski J, Mintz GS, Dilcher CE, Kotani J, Kruk M, et al. Incidence and mechanism of late stent malapposition after phosphorus-32 radioactive stent implantation. Am J Cardiol. 2003;92:970–972
  13. Okura H, Lee DP, Lo S, Yeung AC, Handa Y, Waksman R, et al. Late incomplete apposition with excessive remodeling of the stented coronary artery following intravascular brachytherapy. Am J Cardiol. 2003;92:587–590
  14. Dilcher CE, Chan RC, Pregowski J, Kalinczuk L, Mintz GS, Kotani J, et al. Dose volume histogram assessment of late stent malapposition after intravascular brachytherapy. Cardiovasc Radiat Med. 2002;3:190–192
  15. Degertekin M, Regar E, Tanabe K, Lemos P, Lee CH, Smits P, et al. Evaluation of coronary remodeling after sirolimus-eluting stent implantation by serial three-dimensional intravascular ultrasound. Am J Cardiol. 2003;91:1046–1050
  16. Shah VM, Mintz GS, Apple S, Weissman NJ. Background incidence of late malapposition after bare-metal stent implantation. Circulation. 2002;106:1753–1755
  17. van der Hoeven BL, Liem SS, Jukema JW, Suraphakdee N, Putter H, Dijkstra J, et al. Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! Intervention Study. J Am Coll Cardiol. 2008;51:618–626
  18. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: an intravascular ultrasound analysis. Circulation. 2003;108:2747–2750
  19. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: an intravascular ultrasound analysis with long-term follow-up. Circulation. 2006;113:414–419
  20. Hoffmann R, Morice MC, Moses JW, Fitzgerald PJ, Mauri L, Breithardt G, et al. Impact of late incomplete stent apposition after sirolimus-eluting stent implantation on 4-year clinical events: intravascular ultrasound analysis from the multicentre, randomised, RAVEL, E-SIRIUS and SIRIUS trials. Heart. 2008;94:322–328
  21. Jimenez-Quevedo P, Sabate M, Angiolillo DJ, Costa MA, Alfonso F, Gomez-Hospital JA, et al. Vascular effects of sirolimus-eluting versus bare-metal stents in diabetic patients: three-dimensional ultrasound results of the Diabetes and Sirolimus-Eluting Stent (DIABETES) Trial. J Am Coll Cardiol. 2006;47:2172–2179
  22. Hirohata A, Ako J, Sakurai R, Fearon WF, Caputo R, Mishkel G, et al. Impact of direct coronary stenting on neointimal distribution within sirolimus-eluting stents: IVUS subanalysis form the DIRECT trial. J Am Coll Cardiol. 2005;45:70A
  23. Costa MA, Sabate M, Kay IP, de Feyter PJ, Kozuma K, Serrano P, et al. Three-dimensional intravascular ultrasonic volumetric quantification of stent recoil and neointimal formation of two new generation tubular stents. Am J Cardiol. 2000;85:135–139
  24. Hoffmann R, Mintz GS, Popma JJ, Satler LF, Pichard AD, Kent KM, et al. Chronic arterial responses to stent implantation: a serial intravascular ultrasound analysis of Palmaz-Schatz stents in native coronary arteries. J Am Coll Cardiol. 1996;28:1134–1139
  25. Nakamura M, Nishikawa H, Mukai S, Setsuda M, Nakajima K, Tamada H, et al. Impact of coronary artery remodeling on clinical presentation of coronary artery disease: an intravascular ultrasound study. J Am Coll Cardiol. 2001;37:63–69
  26. Miyazawa A, Shimada Y, Courtney BK, Sakurai R, Nakamura M, Junya A, et al. Characteristics of late incomplete stent apposition: a comparison among bare metal stents, intracoronary radiation, and drug-eluting stents. Circulation. 2005;112:736
  27. Nakatogawa T, Hibi K, Furukawa E, Sugano T, Kosuge M, Takamura T, et al. Impact of peri-stent remodeling on in-stent neointimal proliferation in acute myocardial infarction. Am J Cardiol. 2004;94:769–771
  28. Stabile E, Escolar E, Weigold G, Weissman NJ, Satler LF, Pichard AD, et al. Marked malapposition and aneurysm formation after sirolimus-eluting coronary stent implantation. Circulation. 2004;110:e47–e48
  29. Nebeker JR, Virmani R, Bennett CL, Hoffman JM, Samore MH, Alvarez J, et al. Hyper-sensitivity cases associated with drug-eluting coronary stents: a review of available cases from the Research on Adverse Drug Events and Reports (RADAR) project. J Am Coll Cardiol. 2006;47:175–181
  30. Sanchez-Recalde A, Moreno R, Barreales L, Rivero F, Galeote G, Jimenez-Valero S, et al. Risk of late-acquired incomplete stent apposition after drug-eluting stent versus bare-metal stent. A meta-analysis from 12 randomized trials. J Invasive Cardiol. 2008;20:417–422
  31. Airoldi F, Di Mario C, Stankovic G, Briguori C, Carlino M, Chieffo A, et al. Clinical and angiographic outcome of directional atherectomy followed by stent implantation in de novo lesions located at the ostium of the left anterior descending coronary artery. Heart. 2003;89:1050–1054
  32. Bramucci E, Angoli L, Merlini PA, Barberis P, Laudisa ML, Colombo E, et al. Adjunctive stent implantation following directional coronary atherectomy in patients with coronary artery disease. J Am Coll Cardiol. 1998;32:1855–1860
  33. Uren NG, Schwarzacher SP, Metz JA, Lee DP, Honda Y, Yeung AC, et al. Predictors and outcomes of stent thrombosis: an intravascular ultrasound registry. Eur Heart J. 2002;23:124–132
  34. Waksman R. Late thrombosis after radiation. Sitting on a time bomb. Circulation. 1999;100:780–782
  35. Hong MK, Mintz GS, Lee CW, Park DW, Lee SW, Kim YH, et al. Impact of late drug-eluting stent malapposition on 3-year clinical events. J Am Coll Cardiol. 2007;50:1515–1516
  36. Colombo A, Latib A. Late incomplete stent apposition after drug-eluting stent implantation: a true risk factor or “an innocent bystander”?. Heart. 2008;94:253–254
  37. Schwartz RS, Chronos NA, Virmani R. Preclinical restenosis models and drug-eluting stents: still important, still much to learn. J Am Coll Cardiol. 2004;44:1373–1385
  38. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxel-eluting stents. Circulation. 2005;112:270–278
  39. Virmani R, Guagliumi G, Farb A, Musumeci G, Grieco N, Motta T, et al. Localized hypersensitivity and late coronary thrombosis secondary to a sirolimus-eluting stent: should we be cautious?. Circulation. 2004;109:701–705
  40. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol. 2006;48:193–202

PII: S1553-8389(09)00045-1

doi: 10.1016/j.carrev.2009.02.002

Cardiovascular Revascularization Medicine
Volume 10, Issue 4 , Pages 236-246 , October 2009

Article Tools

* Image Usage & Resolution